Occipital Nerve Stimulation (ONS) for Migraine: OPTIMISE
Stopped early · Not applicable
Conditions studied: Migraine Disorders
In brief
The primary objective of this study is to evaluate the safety and efficacy of occipital nerve stimulation (ONS) using the Boston Scientific Corporation (BSC) Precision™ System in the management of intractable chronic migraine, when used in conjunction with anti-migraine medications.
Key facts
- Study ID
- NCT01775735
- Run by
- Boston Scientific Corporation
- People needed
- 28
- Starts
- 2013-04-10
- Expected to finish
- 2017-01-19
- Last updated by the study team
- 2020-11-13
Who can join
Age: 21 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Boston Scientific Clinical Research Information Toll Free Number — Valencia, California, United States
- University of Illinois at Chicago (Implanting Physician) — Chicago, Illinois, United States
- Diamond Headache Clinic (Headache Physician) — Chicago, Illinois, United States
- Willis-Knighton River Cities Interventional Pain Specialist (Headache & Implanting Physician) — Shreveport, Louisiana, United States
- Henry Ford Hospital (Headache Physician) — Detroit, Michigan, United States
- Henry Ford Medical Group (Implanting Physician) — West Bloomfield, Michigan, United States
- Mercy Pain Management -Surgery Center (Implanting Physician) — Springfield, Missouri, United States
- Clinvest Research, LLC (Headache Physician) — Springfield, Missouri, United States
- NYU Medical Center (Implanting Physician) — New York, New York, United States
- Montefiore Headache Center (Headache Physician) — The Bronx, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.